Female genital warts: Global trends and treatments

Infectious Diseases in Obstetrics and Gynecology

Volumn 9, Issue 3, 2001, Pages 149-154

  Gall, S A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Anogenital cancer; Human papillomavirus; Imiquimod; Patient applied therapy

Indexed keywords

IMIQUIMOD;

ARTICLE; CANCER RISK; CONDYLOMA; DISEASE TRANSMISSION; DRUG EFFICACY; GENITAL TRACT CANCER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; INFECTION PREVENTION; INFECTION RISK; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; UTERINE CERVIX CANCER;

EID: 0034898342     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1155/S1064744901000278     Document Type: Article

References (32)

1. Knowledge of human papillomavirus infection among young adult men and women: Implications for health education and research
2. Genital warts and their treatment
3. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States
4. Biology and pathological associations of the human papillomaviruses: A review
5. Human papillomavirus infection in women. Special aspects of infectious diseases in women
6. Epidemiology of genital human papillomavirus infection
7. Condyloma acuminatum in Rochester, Minn, 1950-1978. II. Anaplasias and unfavorable outcomes
8. Epidemiology and modes of transmission
9. Epidemiology of genital warts in England and Wales: 1971 to 1994
10. New cases seen at genitourinary medicine clinics: England 1997
11. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study
12. Epidemiology of anogenital warts and cancer
13. The association of smoking and risk of condyloma acuminatum in women
14. History of genital warts in 10 838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history
15. Spectrum of genital human papillomavirus infection in a female adolescent population
16. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus
17. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions
18. Immunological events in regressing genital warts
19. Human papillomavirus infection and genital warts: Update on epidemiology and treatment
20. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
21. 1998 Guidelines for treatment of sexually transmitted diseases
22. Ten year follow-up study of women presenting to a genitourinary medicine clinic with anogenital warts
23. Condylomata acuminata in children: Frequent association with human papillomaviruses responsible for cutaneous warts
24. Cancer associated human papillomaviruses: Perinatal transmission and persistence
25. An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle
26. Follow-up of men with genital papilloma virus infection. Psychosexual aspects
27. Psychological aspects of genital human papillomavirus infection: A preliminary report
28. Therapeutic approaches to genital warts
29. Self-administered topical 5% imiquimod cream for external anogenital warts
30. UK National guidelines on sexually transmitted infections and closely related conditions
31. Modeling the impact of treatment options in genital warts: Patient-applied versus physician-administered therapies
32. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial